Company Overview and News

47
Can ExxonMobil's New LNG Import Facility Benefit Australia?

2018-06-18 zacks
Exxon Mobil Corporation (XOM - Free Report) recently disclosed its intention to import liquefied natural gas (LNG) through the east coast of Australia. The largest publicly traded energy company is one of the leading gas suppliers in the southeastern part of Australia and the move is expected to retain its hold in the market, while staying ahead of competitors. The primary reason for the import is gas shortage, which is anticipated to hit the market in 2021.
HD BLT XOM BHPBF AGLNF AGLNY DK BHP HFC BBL MARUF BHP BHPLF

1
Japan-India JV wins contract for Bangladesh’s first mass transit system

2018-06-12 japantimes.co.jp
NEW DELHI – A joint venture between trading house Marubeni Corp. and an Indian engineering and construction firm has won a contract for Bangladesh’s first mass rapid transit system, called the Dhaka MRT Line 6.
MARUF

1
Honda Aircraft starts taking business jet orders in Japan

2018-06-06 japantimes.co.jp
Honda Aircraft Co.’s “flying sports car” is set for take-off in Japan after the firm announced Wednesday it has begun accepting orders for its private business jet, HondaJet Elite, from domestic customers.
MARUF

1
Honda to start selling Hondajet in Japan next year

2018-06-06 reuters
TOKYO (Reuters) - Honda Motor Co (7267.T) on Wednesday said it would start selling its six-seater business jet in Japan next year, as it seeks to expand global sales by tapping into demand from a growing class of high net-worth individuals.
MARUF

1
Forrest to build NSW's first LNG import terminal at Port Kembla

2018-06-04 theage.com.au
Fortescue Metals chairman Andrew "Twiggy" Forrest’s Australian Industrial Energy will build a floating LNG import terminal in Port Kembla to bring more gas to NSW and Victoria as soon as 2020.
MARUF DUETF DUE

1
Forrest to build NSW's first LNG import terminal at Port Kembla

2018-06-04 smh.com.au
Fortescue Metals chairman Andrew "Twiggy" Forrest’s Australian Industrial Energy will build a floating LNG import terminal in Port Kembla to bring more gas to NSW and Victoria as soon as 2020.
MARUF DUETF DUE

5
Duterte: NPAs also to benefit from power plant

2018-06-01 newsinfo.inquirer.net
FOR STABLE SUPPLY President Duterte (center) joins officials of Aboitiz Power and TeaM Energy at the inauguration of the 420-megawatt Pagbilao 3 power plant in Quezon province on Thursday. Seated with Mr. Duterte are (front row, from left) Jera Co. Inc. Senior vice president Toshiro Kodama, Energy Secretary Alfonso Cusi, Aboitiz Power chair Erramon Aboitiz; and Marubeni Corp. senior executive officer Yasuo Hirota.
ABZPF ABZPY MARUF AP

1
‘Dawn' of Asia Offshore Wind Boom Lures Japanese Trading Houses - Bloomberg

2018-05-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
MARUF SSUMF

1
LT Construction bags Rs 3,191 cr order for Dhaka Metro

2018-05-25 moneycontrol
Larsen & Toubro (L&T) today said L&T Construction has bagged a Rs 3,191 crore order from Dhaka Mass Transit Company for construction of a railway line for Dhaka Metro. L&T said it has secured the order in JV with Marubeni Corporation (Japan) through an international competitive bidding process.
MARUF

1
Japan snaps up China-bound sorghum amid Beijing-Washington trade spat

2018-05-18 japantimes.co.jp
Japanese buyers have purchased between 150,000 and 180,000 tons of U.S. sorghum carried by three vessels that were previously bound for China amid a trade spat between Beijing and Washington, according to five industry sources with knowledge of the deals.
ITOCY TYHOF ITOCF MARUF 8015

60
Teekay Corporation Reports First Quarter 2018 Results

2018-05-17 globenewswire
HAMILTON, Bermuda, May 17, 2018 (GLOBE NEWSWIRE) -- Teekay Corporation (Teekay or the Company) (NYSE:TK) today reported the Company's results for the quarter ended March 31, 2018. These results include the Company’s two publicly-listed consolidated subsidiaries Teekay LNG Partners L.P. (Teekay LNG) (NYSE:TGP) and Teekay Tankers Ltd. (Teekay Tankers) (NYSE:TNK) and one equity-accounted investment in publicly-listed Teekay Offshore Partners L.
TOO TNK RDS.B TK RDS.A XOM EXM PMOIF DTK RDSB RDSA HUSKF PMO TGP SU HSE RYDBF MARUF MUR.WI MUR RYDAF PMOIY SU

33
Teekay LNG Partners Reports first Quarter 2018 Results

2018-05-17 globenewswire
HAMILTON, Bermuda, May 17, 2018 (GLOBE NEWSWIRE) -- Teekay GP L.L.C., the general partner of Teekay LNG Partners L.P. (Teekay LNG or the Partnership) (NYSE:TGP), today reported the Partnership’s results for the quarter ended March 31, 2018.
RDS.B TK RDS.A EXM DTK RDSB RDSA TGP.PRA TGP.PRB TGP RYDBF MARUF RYDAF

1
METALS-Copper inches higher on Chinese data but dollar weighs

2018-05-16 reuters
LONDON, May 16 (Reuters) - Copper rebounded on Wednesday following two straight sessions of losses on upbeat Chinese home price data but a stronger dollar reigned in gains.
MARUF

1
Gas giants swap roles as biggest buyer turns to Australia

2018-05-15 worldoil
Australia, soon to become the world’s biggest exporter of liquefied natural gas, is now turning to the largest buyer Japan as it seeks to import the fuel to ease a domestic supply crunch.
AGLNY AGLNF MARUF

1
Gas Giants Swap Roles as Biggest Buyer Becomes Australian Savior - Bloomberg

2018-05-15 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
AGLNY AGLNF MARUF

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...